Cite
HARVARD Citation
Sorigue, M. et al. (2017). Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose. Leukemia & lymphoma. 58 (4), pp. 916-922. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sorigue, M. et al. (2017). Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose. Leukemia & lymphoma. 58 (4), pp. 916-922. [Online].